{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:00:34Z","timestamp":1790780434262,"version":"4.1.0"},"reference-count":41,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,8,14]]},"DOI":"10.2967\/jnumed.126.272952","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:40:14Z","timestamp":1790779214000},"page":"jnumed.126.272952","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the In Vivo PET Generator\n                    <sup>140<\/sup>\n                    Nd\/\n                    <sup>140<\/sup>\n                    Pr Using a HER2-Targeting Agent"],"prefix":"10.2967","author":[{"given":"Mangi Lal","family":"Godara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey A.","family":"Houson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Lapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026093007400454000_jnumed.126.272952v1.1","doi-asserted-by":"crossref","first-page":"108907","DOI":"10.1016\/j.nucmedbio.2024.108907","article-title":"The future of the radiopharmaceutical sciences","volume":"132\u2013133","author":"Lapi","year":"2024","journal-title":"Nucl Med Biol."},{"key":"2026093007400454000_jnumed.126.272952v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30821-6"},{"key":"2026093007400454000_jnumed.126.272952v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00030-5"},{"key":"2026093007400454000_jnumed.126.272952v1.4","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.7150\/thno.115831","article-title":"Pilot experience of [161Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry","volume":"15","author":"Rosar","year":"2025","journal-title":"Theranostics."},{"key":"2026093007400454000_jnumed.126.272952v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026093007400454000_jnumed.126.272952v1.6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/pharmaceutics13010049","article-title":"Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications","volume":"13","author":"Nelson","year":"2020","journal-title":"Pharmaceutics."},{"key":"2026093007400454000_jnumed.126.272952v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026093007400454000_jnumed.126.272952v1.8","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.7150\/thno.100339","article-title":"Aspects and prospects of preclinical theranostic radiopharmaceutical development","volume":"14","author":"Nelson","year":"2024","journal-title":"Theranostics."},{"key":"2026093007400454000_jnumed.126.272952v1.9","doi-asserted-by":"crossref","first-page":"34991","DOI":"10.1038\/s41598-025-18929-4","article-title":"Production and radiochemistry of the in\u00a0vivo PET generator 140Nd\/140Pr as an imaging surrogate for f-block therapeutic radionuclides","volume":"15","author":"Godara","year":"2025","journal-title":"Sci Rep."},{"key":"2026093007400454000_jnumed.126.272952v1.10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fmed.2017.00098","article-title":"Neodymium-140 DOTA-LM3: evaluation of an in\u00a0vivo generator for PET with a non-internalizing vector","volume":"4","author":"Severin","year":"2017","journal-title":"Front Med (Lausanne)."},{"key":"2026093007400454000_jnumed.126.272952v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07147-x"},{"key":"2026093007400454000_jnumed.126.272952v1.12","first-page":"S921","article-title":"Production of the 140Nd\/140Pr radionuclide generator for biomedical studies","volume":"42","author":"Zeisler","year":"1999","journal-title":"J Labelled Cpd Radiopharm."},{"key":"2026093007400454000_jnumed.126.272952v1.13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21037\/atm-23-153","article-title":"Twenty-five years with HER2 targeted therapy","volume":"12","author":"J\u00f8rgensen","year":"2024","journal-title":"Ann Transl Med."},{"key":"2026093007400454000_jnumed.126.272952v1.14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s11307-016-0951-z","article-title":"[89Zr]trastuzumab: evaluation of radiation dosimetry, safety, and optimal imaging parameters in women with HER2-positive breast cancer","volume":"18","author":"Laforest","year":"2016","journal-title":"Mol Imaging Biol."},{"key":"2026093007400454000_jnumed.126.272952v1.15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s11307-024-01948-4","article-title":"Development of 52Mn labeled trastuzumab for extended time point pet imaging of HER2","volume":"26","author":"Omweri","year":"2024","journal-title":"Mol Imaging Biol."},{"key":"2026093007400454000_jnumed.126.272952v1.16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0020-1693(94)03964-X","article-title":"Stability constants of the lanthanide(III)-1,4,7,10-tetraazacyclododecane-N,N\u2032,N\u2033,N\u2034-tetraacetate complexes","volume":"221","author":"T\u00f3th","year":"1994","journal-title":"Inorganica Chim Acta."},{"key":"2026093007400454000_jnumed.126.272952v1.17","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1021\/acs.inorgchem.9b01277","article-title":"Implementing f-block metal ions in medicine: tuning the size selectivity of expanded macrocycles","volume":"58","author":"Thiele","year":"2019","journal-title":"Inorg Chem."},{"key":"2026093007400454000_jnumed.126.272952v1.18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nimb.2021.10.006","article-title":"Activation cross sections of proton-induced reactions on praseodymium up to 30 MeV","volume":"508","author":"Aikawa","year":"2021","journal-title":"Nucl Instrum Methods Phys Res B."},{"key":"2026093007400454000_jnumed.126.272952v1.19","doi-asserted-by":"crossref","first-page":"44998","DOI":"10.1021\/acsomega.6c03114","article-title":"Improved 140Nd production for the 140Nd\/140Pr in\u00a0vivo generator through target recycling and radiochemical optimization","volume":"11","author":"Godara","year":"2026","journal-title":"ACS Omega."},{"key":"2026093007400454000_jnumed.126.272952v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201709532"},{"key":"2026093007400454000_jnumed.126.272952v1.21","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1038\/s41598-019-47137-0","article-title":"Production and in\u00a0vivo PET\/CT imaging of the theranostic pair 132\/135La","volume":"9","author":"Aluicio-Sarduy","year":"2019","journal-title":"Sci Rep."},{"key":"2026093007400454000_jnumed.126.272952v1.22","doi-asserted-by":"crossref","first-page":"e202300457","DOI":"10.1002\/ejic.202300457","article-title":"Construction of the bioconjugate py\u2010macrodipa\u2010PSMA and its in\u00a0vivo investigations with large 132\/135La3+ and small 47Sc3+ radiometal ions","volume":"26","author":"Hu","year":"2023","journal-title":"Eur J Inorg Chem."},{"key":"2026093007400454000_jnumed.126.272952v1.23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41181-025-00354-7","article-title":"It\u2019s a match: use of the radionuclide theranostic pair 133La\/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies","volume":"10","author":"Trommer","year":"2025","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026093007400454000_jnumed.126.272952v1.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262459"},{"key":"2026093007400454000_jnumed.126.272952v1.25","doi-asserted-by":"crossref","first-page":"14638","DOI":"10.1039\/C7DT01936J","article-title":"Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET\/CT with 152Tb-DOTATOC","volume":"46","author":"Baum","year":"2017","journal-title":"Dalton Trans."},{"key":"2026093007400454000_jnumed.126.272952v1.26","doi-asserted-by":"crossref","first-page":"108994","DOI":"10.1016\/j.nucmedbio.2025.108994","article-title":"Production and purification of radiolabeling-ready 132\/135La from the irradiation of metallic natBa targets with low energy protons","volume":"144-145","author":"Kurakina","year":"2025","journal-title":"Nucl Med Biol."},{"key":"2026093007400454000_jnumed.126.272952v1.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.255794"},{"key":"2026093007400454000_jnumed.126.272952v1.28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/ph15101167","article-title":"Efficient production of the PET radionuclide 133La for theranostic purposes in targeted alpha therapy using the 134Ba(p,2n)133La reaction","volume":"15","author":"Br\u00fchlmann","year":"2022","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026093007400454000_jnumed.126.272952v1.29","doi-asserted-by":"crossref","first-page":"22203","DOI":"10.1038\/s41598-020-79198-x","article-title":"High yield cyclotron production of a novel 133\/135La theranostic pair for nuclear medicine","volume":"10","author":"Nelson","year":"2020","journal-title":"Sci Rep."},{"key":"2026093007400454000_jnumed.126.272952v1.30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/chem.201905202","article-title":"Establishing radiolanthanum chemistry for targeted nuclear medicine applications","volume":"26","author":"Aluicio-Sarduy","year":"2020","journal-title":"Chemistry."},{"key":"2026093007400454000_jnumed.126.272952v1.31","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/s41598-025-91716-3","article-title":"Preclinical evaluation of [13xLa]La-FAP-2286 as a novel theranostic agent for tumors expressing fibroblast activation protein","volume":"15","author":"Shirpour","year":"2025","journal-title":"Sci Rep."},{"key":"2026093007400454000_jnumed.126.272952v1.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265355"},{"key":"2026093007400454000_jnumed.126.272952v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2022.04.007"},{"key":"2026093007400454000_jnumed.126.272952v1.34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1524\/ract.2007.95.6.319","article-title":"A 140Nd\/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA","volume":"95","author":"Zhernosekov","year":"2007","journal-title":"Radiochim Acta."},{"key":"2026093007400454000_jnumed.126.272952v1.35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41557-020-00598-7","article-title":"Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics","volume":"13","author":"Bailey","year":"2021","journal-title":"Nat Chem."},{"key":"2026093007400454000_jnumed.126.272952v1.36","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s00259-024-06811-w","article-title":"Examination of the PET in\u00a0vivo generator 134Ce as a theranostic match for 225Ac","volume":"51","author":"Bauer","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026093007400454000_jnumed.126.272952v1.37","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/ja808534w","article-title":"Macrocyclic receptor exhibiting unprecedented selectivity for light lanthanides","volume":"131","author":"Roca-Sabio","year":"2009","journal-title":"J Am Chem Soc."},{"key":"2026093007400454000_jnumed.126.272952v1.38","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1021\/jacs.0c05217","article-title":"Macrocyclic ligands with an unprecedented size-selectivity pattern for the lanthanide ions","volume":"142","author":"Hu","year":"2020","journal-title":"J Am Chem Soc."},{"key":"2026093007400454000_jnumed.126.272952v1.39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ph5010079","article-title":"89Zr-radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors","volume":"5","author":"Chang","year":"2012","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026093007400454000_jnumed.126.272952v1.40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.060392"},{"key":"2026093007400454000_jnumed.126.272952v1.41","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269741"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:40:18Z","timestamp":1790779218000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":41,"alternative-id":["10.2967\/jnumed.126.272952"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272952","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}